Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6600 | 1465 | 36.9 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
1694 | 2 | MUCOADHESION//THIOMERS//ABSORPTION ENHANCER | 6752 |
6600 | 1 | NASAL DELIVERY//NASAL DRUG DELIVERY//NASAL ABSORPTION | 1465 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NASAL DELIVERY | authKW | 1742854 | 8% | 75% | 112 |
2 | NASAL DRUG DELIVERY | authKW | 1278367 | 6% | 66% | 93 |
3 | NASAL ABSORPTION | authKW | 1149830 | 5% | 69% | 80 |
4 | NASAL ADMINISTRATION | authKW | 687706 | 5% | 50% | 66 |
5 | INTRANASAL DELIVERY | authKW | 529737 | 4% | 46% | 55 |
6 | BRAIN TARGETING | authKW | 410703 | 5% | 30% | 66 |
7 | INTRANASAL ADMINISTRATION | authKW | 400898 | 5% | 27% | 71 |
8 | NOSE TO BRAIN DELIVERY | authKW | 358273 | 1% | 90% | 19 |
9 | NOSE TO BRAIN | authKW | 327115 | 1% | 83% | 19 |
10 | ABSORPTION ENHANCER | authKW | 319036 | 5% | 21% | 73 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 27244 | 78% | 0% | 1139 |
2 | Chemistry, Medicinal | 2601 | 13% | 0% | 191 |
3 | Chemistry, Multidisciplinary | 1281 | 21% | 0% | 311 |
4 | Materials Science, Biomaterials | 187 | 2% | 0% | 31 |
5 | Medicine, Research & Experimental | 92 | 4% | 0% | 61 |
6 | Engineering, Biomedical | 19 | 2% | 0% | 22 |
7 | Otorhinolaryngology | 12 | 1% | 0% | 15 |
8 | Endocrinology & Metabolism | 11 | 2% | 0% | 35 |
9 | Ophthalmology | 8 | 1% | 0% | 19 |
10 | Chemistry, Applied | 7 | 2% | 0% | 22 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TTS TECHNOL | 75025 | 0% | 60% | 6 |
2 | NUCL MED NMD | 62525 | 0% | 100% | 3 |
3 | W PHARMACEUT SERV | 60620 | 1% | 36% | 8 |
4 | HEALTHPARTNERS FDN | 57879 | 1% | 28% | 10 |
5 | PHARMACEUT | 48578 | 18% | 1% | 262 |
6 | BIOMED ENGN MATH | 41683 | 0% | 100% | 2 |
7 | FARMACOTECHNOL BIOFARM | 41416 | 1% | 15% | 13 |
8 | BIOPHARMACEUT DRUG DELIVERY | 34729 | 0% | 33% | 5 |
9 | EXPT OTORHINOLARYNGOL | 34438 | 1% | 18% | 9 |
10 | MED ELEMENTAL TOXICOL | 27787 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 51088 | 13% | 1% | 197 |
2 | DRUG DELIVERY | 43384 | 4% | 4% | 52 |
3 | PHARMACEUTICAL RESEARCH | 26002 | 7% | 1% | 100 |
4 | JOURNAL OF DRUG TARGETING | 20336 | 3% | 3% | 39 |
5 | JOURNAL OF PHARMACEUTICAL SCIENCES | 17789 | 7% | 1% | 98 |
6 | JOURNAL OF OCULAR PHARMACOLOGY | 12204 | 1% | 4% | 14 |
7 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 10397 | 3% | 1% | 42 |
8 | STP PHARMA SCIENCES | 9135 | 1% | 3% | 17 |
9 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 8068 | 3% | 1% | 38 |
10 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 6449 | 3% | 1% | 50 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NASAL DELIVERY | 1742854 | 8% | 75% | 112 | Search NASAL+DELIVERY | Search NASAL+DELIVERY |
2 | NASAL DRUG DELIVERY | 1278367 | 6% | 66% | 93 | Search NASAL+DRUG+DELIVERY | Search NASAL+DRUG+DELIVERY |
3 | NASAL ABSORPTION | 1149830 | 5% | 69% | 80 | Search NASAL+ABSORPTION | Search NASAL+ABSORPTION |
4 | NASAL ADMINISTRATION | 687706 | 5% | 50% | 66 | Search NASAL+ADMINISTRATION | Search NASAL+ADMINISTRATION |
5 | INTRANASAL DELIVERY | 529737 | 4% | 46% | 55 | Search INTRANASAL+DELIVERY | Search INTRANASAL+DELIVERY |
6 | BRAIN TARGETING | 410703 | 5% | 30% | 66 | Search BRAIN+TARGETING | Search BRAIN+TARGETING |
7 | INTRANASAL ADMINISTRATION | 400898 | 5% | 27% | 71 | Search INTRANASAL+ADMINISTRATION | Search INTRANASAL+ADMINISTRATION |
8 | NOSE TO BRAIN DELIVERY | 358273 | 1% | 90% | 19 | Search NOSE+TO+BRAIN+DELIVERY | Search NOSE+TO+BRAIN+DELIVERY |
9 | NOSE TO BRAIN | 327115 | 1% | 83% | 19 | Search NOSE+TO+BRAIN | Search NOSE+TO+BRAIN |
10 | ABSORPTION ENHANCER | 319036 | 5% | 21% | 73 | Search ABSORPTION+ENHANCER | Search ABSORPTION+ENHANCER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PANDEY, AN , KUMAR, A , JAIN, SK , (2016) NASAL-NANOTECHNOLOGY: REVOLUTION FOR EFFICIENT THERAPEUTICS DELIVERY.DRUG DELIVERY. VOL. 23. ISSUE 3. P. 681 -693 | 94 | 58% | 8 |
2 | MISRA, A , KHER, G , (2012) DRUG DELIVERY SYSTEMS FROM NOSE TO BRAIN.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 13. ISSUE 12. P. 2355 -2379 | 105 | 57% | 11 |
3 | WARNKEN, ZN , SMYTH, HDC , WATTS, AB , WEITMAN, S , KUHN, JG , WILLIAMS, RO , (2016) FORMULATION AND DEVICE DESIGN TO INCREASE NOSE TO BRAIN DRUG DELIVERY.JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY. VOL. 35. ISSUE . P. 213 -222 | 69 | 83% | 0 |
4 | PIRES, A , FORTUNA, A , ALVES, G , FALCAO, A , (2009) INTRANASAL DRUG DELIVERY: HOW, WHY AND WHAT FOR?.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. VOL. 12. ISSUE 3. P. 288-311 | 85 | 60% | 104 |
5 | DAVIS, SS , ILLUM, L , (2003) ABSORPTION ENHANCERS FOR NASAL DRUG DELIVERY.CLINICAL PHARMACOKINETICS. VOL. 42. ISSUE 13. P. 1107-1128 | 91 | 68% | 85 |
6 | COSTANTINO, HR , ILLUM, L , BRANDT, G , JOHNSON, PH , QUAY, SC , (2007) INTRANASAL DELIVERY: PHYSICOCHEMICAL AND THERAPEUTIC ASPECTS.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 337. ISSUE 1-2. P. 1-24 | 106 | 43% | 183 |
7 | DHURIA, SV , HANSON, LR , FREY, WH , (2010) INTRANASAL DELIVERY TO THE CENTRAL NERVOUS SYSTEM: MECHANISMS AND EXPERIMENTAL CONSIDERATIONS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 99. ISSUE 4. P. 1654-1673 | 68 | 48% | 273 |
8 | CASETTARI, L , ILLUM, L , (2014) CHITOSAN IN NASAL DELIVERY SYSTEMS FOR THERAPEUTIC DRUGS.JOURNAL OF CONTROLLED RELEASE. VOL. 190. ISSUE . P. 189 -200 | 63 | 60% | 34 |
9 | BADHAN, RKS , KAUR, M , LUNGARE, S , OBUOBI, S , (2014) IMPROVING BRAIN DRUG TARGETING THROUGH EXPLOITATION OF THE NOSE-TO-BRAIN ROUTE: A PHYSIOLOGICAL AND PHARMACOKINETIC PERSPECTIVE.CURRENT DRUG DELIVERY. VOL. 11. ISSUE 4. P. 458 -471 | 76 | 60% | 6 |
10 | HINCHCLIFFE, M , ILLUM, L , (1999) INTRANASAL INSULIN DELIVERY AND THERAPY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 35. ISSUE 2-3. P. 199 -234 | 94 | 68% | 91 |
Classes with closest relation at Level 1 |